Pharmacokinetics of chemotherapy.

J W Cullen
{"title":"Pharmacokinetics of chemotherapy.","authors":"J W Cullen","doi":"10.1177/104345428900600210","DOIUrl":null,"url":null,"abstract":"John W. Cullen, MD, is a Pediatric Oncologist at Children’s Hospital in Denver, Colorado. The optimal utilization of a chemotherapeutic agent depends on an understanding of the factors involved in absorption, distribution, biotransformation, cellular uptake, method of action and routes of excretion. This presentation gave a brief introduction to these concepts. The treatment of childhood cancer usually involves the use of multiple drugs. The use of drugs from different classes with different methods of action theoretically would give a higher chance of cell kill. The classes of drugs most frequently used in childhood cancer therapy are antimetabolites, alkylating agents, antibiotics, antistathmokinetic agents and some miscellaneous drugs. Antimetabolites may interfere with DNA, RNA or protein synthesis. Thioguanine and 6-mercaptopurine are examples of antimetabolites which interfere with proper production of DNA. Alkylating agents such as nitrogen mustard and cyclophosphamide bind from one chain of DNA to another. This process known as intercalation interferes with separation of the chains, subsequent replication and division. Daunomycin, an antibiotic, also intercalates within the DNA strands while Bleomycin causes scission of the strands. Vincristine is an antistathmokinetic agent. It destroys the ability of the chromosomes to retract from the center of a cell","PeriodicalId":77742,"journal":{"name":"Journal of the Association of Pediatric Oncology Nurses","volume":"6 2","pages":"21-2"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/104345428900600210","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Association of Pediatric Oncology Nurses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/104345428900600210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

John W. Cullen, MD, is a Pediatric Oncologist at Children’s Hospital in Denver, Colorado. The optimal utilization of a chemotherapeutic agent depends on an understanding of the factors involved in absorption, distribution, biotransformation, cellular uptake, method of action and routes of excretion. This presentation gave a brief introduction to these concepts. The treatment of childhood cancer usually involves the use of multiple drugs. The use of drugs from different classes with different methods of action theoretically would give a higher chance of cell kill. The classes of drugs most frequently used in childhood cancer therapy are antimetabolites, alkylating agents, antibiotics, antistathmokinetic agents and some miscellaneous drugs. Antimetabolites may interfere with DNA, RNA or protein synthesis. Thioguanine and 6-mercaptopurine are examples of antimetabolites which interfere with proper production of DNA. Alkylating agents such as nitrogen mustard and cyclophosphamide bind from one chain of DNA to another. This process known as intercalation interferes with separation of the chains, subsequent replication and division. Daunomycin, an antibiotic, also intercalates within the DNA strands while Bleomycin causes scission of the strands. Vincristine is an antistathmokinetic agent. It destroys the ability of the chromosomes to retract from the center of a cell
化疗的药代动力学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信